Both in Pharmaceuticals
Matinas BioPharma Holdings vs Oragenics
Over the past year MTNB returned −92.7% and OGEN returned −69.5%; their daily moves had a correlation of 0.03.
MTNB −92.7% OGEN −69.5%Growth of $1, one year, split-adjusted
| Metric | MTNB | OGEN |
|---|---|---|
| Price | $1.51 | $0.3740 |
| Market cap | $1.5M | $1.7M |
| Today | −20.53% | −0.05% |
| 1 month | −37.6% | −22.1% |
| 6 months | −85.6% | −39.7% |
| Year to date | −82.8% | −52.2% |
| 1 year | −92.5% | −71.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $755.0K | $3.9M |
| Dividend yield | — | — |
| Volatility (60d) | 775.0% | 50.4% |
| Short % of float | 0.5% | 24.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).